To objectively evaluate the clinical efficacy of continuous acupuncture in the treatment of pain.Methods:The National Knowledge Infrastructure Database (CNKI),China Academic Journals Database (CSPD),Chinese Sci-tech Journals Database (CCD),Chinese Biomedical Literature Database (CBM),PubMed,Cochrane Library,etc.were searched; time was from 1996 to2019; random Controlled trials (RCT) was included; we required all the test groups to use FU's subcataneous needling therapy or FU's subcataneous needlings as the main therapy,while the control group used other therapies; the quality evaluation was carried out according to Cochrane System Reviewer Manual 5.1.0,and the Review-Manager 5.3 software was used for Meta analysis.Results:Finally,a total of 27 literature which met the inclusion criteria,with 2 397 cases combined were included.Heterogeneity evaluation:Heterogeneity numerical test (χ2=8.97,P=1.00,I2=0%＜50%) was determined as no heterogeneity or small.The good left-right symmetry of the funnel graph indicated that the risk of bias in this study was not high.Meta-analysis results:FU's subcataneous needling or combined with other therapies were better than other therapies for pain,and the difference in effective rate was statistically significant (OR=4.55,95% CI 3.38,6.14,Z=9.93,P<0.000 01).FU's subcataneous needling or FU's subcataneous needling as the main therapy were compared with different interventions in the control group.The clinical efficacy of FU's subcataneous needling was better than conventional acupuncture and drug therapy.Conclusion:The treatment of pain with FU's subcataneous needling has relative advantages and be popularized in clinical practice.Fu's subcataneous needling therapy for pain has a comparative advantage,which can be promoted in clinical practice.At the same time,FU's subcataneous needling therapy has potential advantages,and we need more randomized controlled studies to further verify the above results.